- Article metrics
- Last updated: Thu, 29 Jan 2026 6:41:49 Z
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Access & Citations
-
- 87k
- Article Accesses
-
- 314
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 196 tweeters
- 2 blogs
- 132 news outlets
- 1 Redditors
- 1 Video uploaders
- 1 Wikipedia page
- 539 Mendeley
This article is in the 99th percentile (ranked 518th) of the 518,712 tracked articles of a similar age in all journals and the 94th percentile (ranked 5th) of the 89 tracked articles of a similar age in Nature Medicine
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Oxford says vaccine has good immune response with two-dose...
Investing.com - UK -
Oxford vaccine stimulates broad antibody and T cell functions
FirstWord Pharma -
News story from Jersey Evening Post on Thursday 17 December 2020
Jersey Evening Post -
5th January 2021 - the COVID-19 coronavirus compendium
Nature Microbiology Community
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.